Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2006-2-10
pubmed:abstractText
Treatment of chronic hepatitis B (CHB) involves a number of complex and controversial issues. Expert opinions may differ from those of practicing hepatologists and gastroenterologists. We aimed to explore this issue further after a critical review of the literature.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Adenine, http://linkedlifedata.com/resource/pubmed/chemical/Alanine Transaminase, http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents, http://linkedlifedata.com/resource/pubmed/chemical/DNA, Viral, http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis B e Antigens, http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha, http://linkedlifedata.com/resource/pubmed/chemical/Interferons, http://linkedlifedata.com/resource/pubmed/chemical/Lamivudine, http://linkedlifedata.com/resource/pubmed/chemical/Phosphonic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols, http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins, http://linkedlifedata.com/resource/pubmed/chemical/adefovir, http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2a, http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2a
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
1542-3565
pubmed:author
pubmed:issnType
Print
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
233-48
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:16469685-Adenine, pubmed-meshheading:16469685-Alanine Transaminase, pubmed-meshheading:16469685-Antiviral Agents, pubmed-meshheading:16469685-Biopsy, pubmed-meshheading:16469685-Clinical Competence, pubmed-meshheading:16469685-DNA, Viral, pubmed-meshheading:16469685-Disease Progression, pubmed-meshheading:16469685-Drug Therapy, Combination, pubmed-meshheading:16469685-Endpoint Determination, pubmed-meshheading:16469685-Hepatitis B, Chronic, pubmed-meshheading:16469685-Hepatitis B e Antigens, pubmed-meshheading:16469685-Hepatitis B virus, pubmed-meshheading:16469685-Humans, pubmed-meshheading:16469685-Interferon-alpha, pubmed-meshheading:16469685-Interferons, pubmed-meshheading:16469685-Lamivudine, pubmed-meshheading:16469685-Liver, pubmed-meshheading:16469685-Patient Selection, pubmed-meshheading:16469685-Phosphonic Acids, pubmed-meshheading:16469685-Polyethylene Glycols, pubmed-meshheading:16469685-Recombinant Proteins, pubmed-meshheading:16469685-Societies, Medical, pubmed-meshheading:16469685-Virus Replication
pubmed:year
2006
pubmed:articleTitle
Chronic hepatitis B: a critical appraisal of current approaches to therapy.
pubmed:affiliation
Ochsner Clinic Foundation, 1514 Jefferson Highway, New Orleans, LA 70121, USA. rperrillo@ochsner.org
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't